Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

December 30, 2027

Conditions
Gynecologic CancersOvarian CancerEndometrial CancersCervical CancersVulvar CancerAnastomotic Leaks
Interventions
DRUG

Indocyanine Green

Indocyanine green (ICG), administered intravenously at a dose of 2.5 mg/ml, will be used during surgery to evaluate bowel anastomosis perfusion through near-infrared fluorescence imaging.

DEVICE

Near-Infrared Fluorescence Imaging System

A near-infrared fluorescence imaging device will be used intraoperatively to visualize indocyanine green (ICG) fluorescence, assessing the perfusion of bowel anastomoses during gynecologic oncology surgery.

Trial Locations (1)

34093

Istanbul University, Istanbul Faculty of Medicine, Department of Gynecologic Oncology, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER